Media

  • New Senior Assay Development Scientist job posting

    2 June 2019
    67 Views
    Comments are off for this post

    Interested in a career with Velox?  Check out the Velox Careers page.  A new position has just been posted for a Senior Director or Vice President of Assay Development.  We’re looking for hardworking, motivated individuals to join our team in building the next generation of diagnostics.  Apply today!

    Continue Reading
  • Velox Q1 2019 Newsletter

    12 March 2019
    53 Views
    Comments are off for this post

    We are having a great start to 2019! Here we will highlight our recent big win at the UC Systemwide Pitch Competition and the progress we are making on several R&D projects in our pipeline, particularly in cancer liquid biopsy and further expansion of the detection capability of our IC3D droplet digital detection platform. Read our full Q1 2019 newsletter here.

    Continue Reading
  • Velox Biosystems Wins Big at UC Entrepreneur Pitch Competition

    26 February 2019
    66 Views
    Comments are off for this post

    Beating out the competition, UCI Applied Innovation startup Velox Biosystems presented their winning pitch at the third annual UC Entrepreneur Pitch Competition in Monterey, California. Check out the write up from Applied Innovation to learn more.

    Continue Reading
  • Velox publishes new article on ultra-sensitive cancer liquid biopsy

    4 February 2019
    38 Views
    Comments are off for this post

    In collaboration with Prof. Weian Zhao’s Lab at UC Irvine, Velox has published an article demonstrating the superior sensitivity of IC3D in liquid biopsy applications. In the publication, “An Ultrasensitive Test for Profiling Circulating Tumor DNA using Integrated Comprehensive Droplet Digital Detection” (Lab Chip, 2019), we demonstrated that the IC3D system can detect oncogenic KRAS G12D mutant alleles against a high background of genomic DNA at a sensitivity of 0.00125 – 0.005%, or 50 to 1,000x more sensitive than leading liquid biopsy ddPCR and qPCR platforms, respectively.

    Continue Reading
  • Velox Q2/Q3 2018 Newsletter

    22 October 2018
    59 Views
    Comments are off for this post

    After we highlighted our Point-of-care UTI Screening and Antibiotic Resistance Test project in the last Velox newsletter, a top global diagnostics company contacted us unexpectedly. They acknowledged that UTI represents a very significant, but somewhat neglected market opportunity, and that they have been looking for solutions for the point-of-care setting. Learn more about Velox’s recent progress in developing solutions for UTI screening and rapid antibiotic resistance testing along with other applications of our platform technology in our Q2/Q3 2018 newsletter.

    Continue Reading
  • UTI Product Demo

    9 September 2018
    0 Views
    Comments are off for this post

    We have made HUGE progress on the Urinary Tract Infection (UTI) project: Rapid, Point-of-Care, UTI Screening and Antibiotic Susceptibility Testing. We will have more announcement in the upcoming Velox Q2/Q3 Newsletter. In the meanwhile, please check out this cool Velox UTI Video.

    Continue Reading
  • Velox Q1 2018 Newsletter

    24 April 2018
    58 Views
    Comments are off for this post

    Right off the bat, we will tell you that this Velox newsletter is different from the previous ones. We will be talking about UTI (Urinary Tract Infection) and a huge clinical milestone that Velox has completed: a blinded clinical feasibility study with 26 patient samples for a rapid UTI diagnostic product. So why should we (and you) be excited about this news? Click here to read our Q1 2018 Newsletter.

    Continue Reading
  • Velox Q3/Q4 2017 Newsletter

    21 December 2017
    124 Views
    Comments are off for this post

    Wow, it seems to be just in the blink of an eye that the year end and the holiday season have almost jumped upon us! A lot has happened in the past six months, so let’s take a quick inventory here of the many accomplishments of our team. Check out the latest news from Velox in our Q3/Q4 Newsletter. And we would also like to take this opportunity to wish our friends, partners, and investors a wonderful holiday season and all the best in 2018!

    Continue Reading
  • Velox Q2 2017 Newsletter

    3 August 2017
    1269 Views
    Comments are off for this post

    Velox has been making some exciting strides in recent months.  Check out the latest news and developments in the 2017 Q2 Velox Quarterly Newsletter.  To keep up to date on the latest from Velox, please subscribe to our mailing list using the widget at the bottom of this page.

    Continue Reading
  • CEO and Co-Founder, Dr. Chris Heylman, Pitches at I Am A UC Entrepreneur Award Luncheon

    2 June 2017
    914 Views
    Comments are off for this post

    CEO and Co-Founder, Dr. Chris Heylman, attended the “I Am A UC Entrepreneur Award Luncheon” on May 5, 2017, in Oakland, CA, hosted by UC President Janet Napolitano and Christine Gulbranson, UC’s Senior Vice President of Innovation and Entrepreneurship.  Dr. Heylman was one of the nineteen winners chosen from more than 300 UC students, faculty, and staff who submitted their 30 sec pitches this past winter as part of the “I am a UC entrepreneur” campaign (see Dr. Heylman’s pitch).  At the luncheon, Dr. Heylman met and pitched Velox’s vision to some of Silicon Valley’s leading venture capitalists.

    Continue Reading